Insmed Operating Margin Analysis
Insmed EBITDA Margin
Insmed Inc Fundamental Drivers RelationshipsComparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info. Insmed Inc is currently regarded as number one stock in retained earnings category among related companies. It is currently regarded as number one stock in price to sales category among related companies . As of the 23rd of February 2024, Price to Sales Ratio is likely to grow to 9.26. Comparative valuation analysis is a catch-all model that can be used if you cannot value Insmed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insmed's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Insmed's earnings, one of the primary drivers of an investment's value.
Insmed Market Capitalization Peer ComparisonStock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insmed's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insmed could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics of similar companies.
Insmed Current Valuation Drivers
About Insmed Fundamental Analysis
|Projected for 2024
|Cost of Revenue
|Revenue to Assets
|Revenue Per Employee
Insmed Investors Sentiment
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.Try AI Portfolio Architect
Complementary Tools for Insmed Stock analysis
Check real value of public entities based on technical and fundamental data
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Check effects of mean-variance optimization against your current asset allocation
All portfolio management and optimization tools to improve performance of your portfolios
|Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Find actively-traded funds from around the world traded on over 30 global exchanges
|My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyze and compare many basic indicators for a group of related or unrelated entities
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst recommendations and target price estimates broken down by several categories
Top statistical indicators that provide insights into how an economy is performing
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Find actively traded Exchange Traded Funds (ETF) in USA
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity